[1] Zeinalian M,Emami MH,Salehi R,et al.Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular,clinicopthological feature [J].J Gastrointest Cancer,2015,46(2):118-125.
[2] Xiao GCh,Zheng YB,Tong ShL, et al. Inhibitotory effects of phosphatidylinositol 3-kinase/serine/threonine protein kinase and mitogen extracellular signal-regulated kinase/extracellular signal-regulated kinase signaling pathway on function of vascular endothelial cells in colon cancer[J].Chinese Journal of Experimental Surgery, 2015; 32(8):1911-1914. (in Chinese)
肖高春,郑勇斌,童仕伦,等.抑制磷脂酰肌醇3激酶/丝氨酸苏氨酸蛋白激酶和丝裂原细胞外信号调节激酶/细胞外信号调节激酶信号通路对结肠癌血管内皮细胞功能的影响[J].中华实验外科杂志,2015; 32(8):1911-1914.
[3] Maurizi G, Babini L, Della Guardia L. Potential role of microRNAs in the regulation of adipocytes liposecretion and adipose tissue physiology[J]. J Cell Physiol, 2018, 233 (12):9077-9086.
[4] Samal B, Sun Y,Steams G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-ce11 colony enhancing factor[J].Mol Cell Bio1,1994,14 (2):1431-1437.
[5] Fukuhara A,Matsuda M,Nishizawa M,et al. Visfatin:a protein secreted by visceral fat that mimics the effects of insuli[J].Science,2005,307 (5708):426-430.
[6] Mohammadi M, Zarghami N, Hedayati M, et al. Synergistic effects of resistin and visfatin as adipocyte derived hormones on telomerase gene expression in ags gastric cancer cell line[J]. Acta Med Iran, 2017, 55(10):621-627.
[7] Behrouzfar K, Alaee M, Nourbakhsh M, et al. Extracellular NAMPT/visfatin causes p53 deacetylation via NAD production and SIRT1 activation in breast cancer cells[J]. Cell Biochem Funct, 2017, 35(6):327-333.
[8] Wang Y, Gao C, Zhang Y, et al. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways[J]. Gynecol Oncol, 2016,143(1):168-178.
[9] Chen M, Wang Y, Li Y, et al. Association of plasma visfatin with risk of colorectal cancer: an observational study of Chinese patients[J]. Asia Pac J Clin Oncol, 2016, 12(1):e65-74.
[10] Xue ShH,Lu ZhY,Zhang TCh, et al.Expression and mechanism of microRNA-940 in breast cancer[J].Acta Anatomica Sinica, 2019, 50(1):56-62. (in Chinese)
薛世航,陆振一,张同成,等. MicroRNA-940在乳腺癌中的表达变化及作用机制[J].解剖学报, 2019, 50(1):56-62.
[11] Shao ZhX, Xie JJ, Xu ZhH, et al. Transfection of microRNA-21 mediating the biological behavior andcellular radiosensitivity of esophageal squamous carcinoma cells[J].Acta Anatomica Sinica,2020,51(3):385-391. (in Chinese)
邵志雄,谢俊杰,徐振华,等. 微小RNA-21转染介导食管鳞癌细胞生物学行为及细胞放射敏感性的变化[J].解剖学报, 2020, 51(3):385-391.
[12] Callegari E,D’Abundo L,Guerriero P,et al. MiR-199a-3p modulates MTOR and PAK4 pathways and inhibits tumor growth in a hepatocellular carcinoma transgenic mouse model[J]. Mol Ther Nucleic Acids,2018,1(11):485-493.
[13] Li SQ,Wang ZH, Mi XG,et al. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway[J].IUBMB Life,2015,67(10):768-777.
[14] Chao CC, Wu PH, Huang HC, et al. Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer[J]. FEBS Lett, 2017, 591(13):1902-1917.
[15] Snezhkina AV, Krasnov GS, Zhikrivetskaya SO, et al. Overexpression of microRNAs miR-9,-98, and-199 correlates with the downregulation of HK2 expression in colorectal cancer[J]. Mol Biol (Mosk), 2018, 52(2):220-230.
[16] Hu WJ,Chen Ch,Huang H, et al.Research progress in the relationship between mir-199a family members and tumors[J].Medical Recapitulate, 2019,25(2):280-285. (in Chinese)
胡文佳,陈晨,黄辉,等. miR-199a 家族与肿瘤关系的研究进展[J]. 医学综述,2019,25(2):280-285.
|